These observations suggest that local administration of IL-4 and/or IL-13 to the healing tendon might be beneficial in accelerating recovery in patients with tendinopathies, without affecting systemic regulation of inflammation or immunity by these cytokines. The gene discussed is IL13; the disease is disease of the tendon.